dalteparin has been researched along with Atheroma in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Dalteparin may inhibit atherosclerotic lesions by downregulating the expression of LOX-1 protein." | 1.42 | Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice. ( Bao, H; Chen, D; Li, W; Miao, Y; Su, L; Yan, Z; Zhang, Q, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artico, M | 1 |
RiganĂ², R | 1 |
Buttari, B | 1 |
Profumo, E | 1 |
Ionta, B | 1 |
Bosco, S | 1 |
Rasile, M | 1 |
Bianchi, E | 1 |
Bruno, M | 1 |
Fumagalli, L | 1 |
Su, L | 1 |
Zhang, Q | 1 |
Bao, H | 1 |
Li, W | 1 |
Miao, Y | 1 |
Yan, Z | 1 |
Chen, D | 1 |
2 other studies available for dalteparin and Atheroma
Article | Year |
---|---|
Protective role of parnaparin in reducing systemic inflammation and atherosclerotic plaque formation in ApoE-/- mice.
Topics: Animals; Apolipoproteins E; Arteries; Disease Models, Animal; Fatty Liver; Fibrinolytic Agents; Gene | 2011 |
Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Dalteparin; Down-Regulation; Mice; Mice, Knockout; Plaq | 2015 |